Method of screening physiologically active substance
OwnerTatsuji Enoki, Shusaku Yamashita +4inventors
InventorsTatsuji Enoki, Shusaku Yamashita, Masatomo Rokushima, Junichi Mineno, Hiroaki Sagawa, Ikunoshin Kato
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of screening a biologically active substance or a candidate substance for a biologically active substance, possessing an activity for controlling gene expression to the same extent to that of DGE; a gene controlling agent which is effective for maintaining homeostasis in a living body, for instance, purposed for mitigation or prevention of stress; and a method of controlling a gene.
Claims23
A method of screening a biologically active substance, characterized in that the method comprises the steps of:
- (1) loading to a living body either 1) a test substance or 2) a compound of the following (i):
- (i) at least one compound selected from the group consisting of a compound represented by the following formula (I):
- 3
- wherein X and Y are H or CH2OH, with proviso that when X is CH2OH, Y is H,
- and when X is H, Y is CH2OH,
- a derivative thereof and a salt thereof;
- and/or
- a compound of the following (ii):
- (ii) at least one compound selected from the group consisting of 3,6-anhydrogalactose represented by the following formula (II):
- 4
- an aldehyde thereof, a hydrate thereof, and a 2-O-methylated product and a 2-O-sulfated product of the foregoing compounds;
- and/or at least one compound selected from the group consisting of soluble saccharide compounds having said compound at reducing end;
- (2) determining an expression level of a gene in the living body of said (1), and comparing resulting values between a case where 1) is loaded and a case where 2) is loaded;
- and
- (3) selecting a test substance which causes a change in an expression level of at least one gene to substantially the same extent as a change where 2) is loaded.
A method of screening a biologically active substance, characterized in that the method comprises the steps of:
- (1) loading a test substance to a living body;
- (2) determining an expression level of a gene in the living body of said (1) and an expression level of a gene in the living body without the loading, and comparing resulting values therebetween;
- and
- (3) selecting a test substance which decreases an expression level of at least one gene selected from the following Group A, Group C, Group E and Group F, and/or increases an expression level of at least one gene selected from the following Group B, Group D and Group G:
- Group A:
- Bone morphogenetic protein-6 [BMP-6 (GenBank Accession No. NM—001718)] gene,
- Chemokine receptor-1 [CCR-1 (GenBank Accession No. NM—001295)] gene,
- Hepatocyte growth factor [HGF (GenBank Accession No. X16323)] gene,
- Intercellular adhesion molecule-1 [ICAM-1 (GenBank Accession No. NM—000201)] gene,
- Interleukin-1β [IL-1β (GenBank Accession No. X02532)] gene,
- Interleukin-16 [IL-16 (GenBank Accession No. M90391)] gene,
- Leukemia inhibitory factor [LIF (GenBank Accession No. NM—002309)] gene,
- Osteopontin [Osteopontin (GenBank Accession No. NM—000582)] gene,
- Tumor necrosis factor-α [TNF-α (GenBank Accession No. X02910)] gene,
- Neuropilin-1 [Neuropilin-1 (GenBank Accession No. NM—003873)] gene,
- signal transducer and activator of transcription 6 [STAT6 (GenBank Accession No. AF067575)] gene, and
- Gene containing Homo Sapiens cDNA:
- FLJ22298 fis, clone HRC04637 (GenBank Accession No. AK025951),
- Group B:
- Heme oxygenase-1 [HO-1 (GenBank Accession No. NM—002133)] gene,
- Thioredoxin reductase-1 (GenBank Accession No. AF106697) gene,
- putative translation initiation factor [SUIL (GenBank Accession No. AF083441)] gene, and
- Homo sapiens hypothetical protein [HSPCO14 (GenBank Accession No. NM—015932)] gene;
- Group C:
- N-myc downstream regulated gene 1 [NDRG1 (GenBank Accession No. NM—006096)] gene,
- adenosine deaminase, RNA specific [ADAR (GenBank Accession No. NM—015841)] gene,
- splicing factor 3b, subunit2 [SF3B2 (GenBank Accession No. NM—006842)] gene,
- interleukin enhancer binding factor 3 [ILF3 (GenBank Accession No. NM—004516)] gene,
- valyl-tRNA synthetase 2 [VARS2 (GenBank Accession No. NM—006295)] gene, and
- Gene containing the nucleotide sequence shown in SEQ ID NO:
- 12 of Sequence Listing;
- Group D:
- eukaryotic translation elongation factor 1 alpha 1 [EEF1A1 (GenBank Accession No. NM—001402)] gene,
- ribosomal protein L17 [RPL17 (GenBank Accession No. NM—000985)] gene,
- ribosomal protein L24 [RPL24 (GenBank Accession No. NM—000986)] gene,
- splicing factor, arginine/serine-rich 2 [SFRS2 (GenBank Accession No. NM—003016)] gene,
- tumor protein, translationally-controlled 1 [TPT1 (GenBank Accession No. NM—003295)] gene,
- ubiquinol-cytochrome c reductase binding protein [UQCRB (GenBank Accession No. NM—006294)] gene,
- ribosomal protein S15a [RPS15A (GenBank Accession No. NM—001019)] gene, and
- ribosomal protein L27 [RPL27 (GenBank Accession No. NM—000988)] gene;
- Group E:
- Interleukin-2 receptor α [IL2RA (GenBank Accession No. X01057)] gene,
- Interleukin-6 [IL6 (GenBank Accession No. X04430)] gene,
- CD166 (GenBank Accession No. Y10183) gene,
- Interferon regulatory factor-1 [IRF1 (GenBank Accession No. X14454)] gene,
- Interleukin-15 receptor α [IL1SRA (GenBank Accession No. U31628)] gene,
- Nuclear factor kappa-b p105 Subunit [NFKB1 (GenBank Accession No. M58603)] gene,
- Caspase-1 [CASP1 (GenBank Accession No. M87507)] gene,
- Interleukin-1β [IL1B (GenBank Accession No. M15330)] gene,
- Tumor necrosis factor-α [TNF-α (GenBank Accession No. X02910)] gene,
- Gro1 oncogene [GRO1 (GenBank Accession No. X54489)] gene,
- Interleukin-1α [IL1A (GenBank Accession No. M28983)] gene,
- Inhibin βA [INHBA (GenBank Accession No. J03634)] gene,
- Interleukin-7 receptor [IL7R (GenBank Accession No. M29696)] gene,
- Precursor B cell colony enhancing factor [PBEF (GenBank Accession No. U02020)] gene,
- Liver and activation regulated chemokine [LARC (GenBank Accession No. U64197)] gene, and
- Interleukin-8 [IL8 (GenBank Accession No. M26383)] gene;
- Group F:
- Colony-stimulating factor-1 receptor [CSF1R (GenBank Accession No. X03663)] gene,
- Chemokine (C-X-C motif) receptor-4 [CXCR4 (GenBank Accession No. AF147204)] gene, and
- Endoglin [ENG (GenBank Accession No. NM—000118)] gene;
- and
- Group G:
- Heme oxygenase-1 [HMOX1 (GenBank Accession No. Z82244)] gene.
Dependencies are inferred from the claim text.